1992
DOI: 10.1093/ajcp/97.1.139
|View full text |Cite
|
Sign up to set email alerts
|

Lymph Node Interdigitating Cell Sarcoma: A Case Report

Abstract: A 54-year-old man was admitted because of right supraclavicular lymphadenopathy of some weeks duration. Computed axial tomography revealed a large multinodular lesion in a supraclavicular lymph node. The patient then had a supraclavicular lymph node biopsy. Light microscopy showed a tumor whose structure was suggestive of an interdigitating cell sarcoma. Enzyme and immunohistochemical analysis showed that the tumor cells possessed membranous adenosine triphosphatase activity, intracytoplasmic S100 protein, sur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
21
0

Year Published

1996
1996
2011
2011

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 33 publications
(21 citation statements)
references
References 3 publications
0
21
0
Order By: Relevance
“…Significant immunophenotypic overlap exists between IDDCT/S and FDCT/S. Markers that can distinguish the two entities include R4/23, CD21, CD35 [29][30][31], and 5 0 nucleotidase activity, which are positive in FDCT/S. On the other hand, ATPase activity [32], S-100 [30,33], and HLA-DR [33,34] positivity are present in IDDCT/S.…”
Section: Interdigitating Dendritic Cell Tumor/sarcomamentioning
confidence: 99%
See 4 more Smart Citations
“…Significant immunophenotypic overlap exists between IDDCT/S and FDCT/S. Markers that can distinguish the two entities include R4/23, CD21, CD35 [29][30][31], and 5 0 nucleotidase activity, which are positive in FDCT/S. On the other hand, ATPase activity [32], S-100 [30,33], and HLA-DR [33,34] positivity are present in IDDCT/S.…”
Section: Interdigitating Dendritic Cell Tumor/sarcomamentioning
confidence: 99%
“…Presence of CD1a in LCT/S helps differentiating it from both IDDCT/S and FDCT/S [35]. In IDDCT/S, T-cell rearrangement has not been identified [36] and the Langerhans' exclusive Birbeck granules are not observed [29][30][31]33,34]. In short, the criteria for diagnosing IDDCT/S include appropriate morphology, paracortical location of the process in the lymph node, strong S-100 positivity, and the lack of CD1a as well as FDCT/S markers.…”
Section: Interdigitating Dendritic Cell Tumor/sarcomamentioning
confidence: 99%
See 3 more Smart Citations